Sinopharm Group Hunan Medical Device Co., Ltd.

China National Pharmaceutical Group (SINOPHARM, referred to as "Sinopharm Group") is a Fortune Global 500 enterprise group directly under the State-owned Assets Supervision and Administration Commission of the State Council, focusing on the healthcare sector with the largest scale, the most complete industrial chain and the strongest comprehensive strength in China. China Medical Instrument Co., Ltd. (CMIC, referred to as "Sinopharm Medical Device") is a subsidiary of Sinopharm Group, founded in 1966, and is the main force of its medical device sector. Sinopharm Group Hunan Medical Device Co., Ltd. was jointly established by Sinopharm Medical Device and Changsha Jiashen Medical Device Co., Ltd. in 2011. Adhering to the corporate philosophy of "Care for Life, Protect Health", the Hunan company takes "let more people enjoy better health services" as its mission, practices the core corporate values of "responsibility, integrity, professionalism, innovation and win-win", and envisions to "become the most respected medical device enterprise with industry competitiveness and international influence". It is committed to providing complete equipment and quality services for medical institutions across Hunan Province, with the positioning as a provincial commercial logistics platform service company for medical devices. The company has a marketing network in all prefecture-level cities across Hunan Province. Its current main businesses involve medical device sales, centralized distribution of hospital consumables, centralized government procurement, equipment maintenance centers, regional disinfection and supply centers, regional diagnostic center laboratories and other fields. We actively participate in the restructuring of public hospitals and fulfill the social responsibility of a central enterprise in various ways. We focus on introducing healthcare development funds and devote ourselves to long-term investment in the medical and health field to solve the bottleneck of development funds for public hospitals, thereby achieving the purpose of providing more patients with efficient and comprehensive medical services, and striving to realize the concept advocated by Sinopharm Group of letting more people enjoy better health services.